{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:55:19Z","timestamp":1781805319628,"version":"3.54.5"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20240976"],"award-info":[{"award-number":["20240976"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Acquired drug resistance is a major cause of failure in gastric cancer treatment. The protein tyrosine phosphatase receptor type E (PTPRE) plays an oncogenic role in certain tumours; however, its function in chemotherapy-resistant gastric cancer remains unclear. Therefore, we analysed PTPRE expression in gastric cancer using The Cancer Genome Atlas. In vitro experiments were then conducted to investigate the effects of PTPRE on the resistance of cancer cells to 5-fluorouracil (5-FU) and its potential mechanisms. The results were further validated in vitro using xenograft studies. We found that PTPRE is upregulated in gastric cancer tissues and participates in the induction of 5-FU resistance. Mechanistic studies revealed that PTPRE suppressed ferroptosis in gastric cancer cells and promoted 5-FU resistance by activating the Src\/FAK pathway to upregulate TRIB3 expression. In summary, PTPRE suppresses ferroptosis in gastric cancer cells via the Src\/FAK\/TRIB3 signalling pathway, thereby inducing 5-FU resistance. Intervention with PTPRE and its downstream targets may represent a potential approach for the clinical treatment of 5-FU-resistant gastric cancer.<\/jats:p>","DOI":"10.1371\/journal.pone.0351846","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:25:36Z","timestamp":1781803536000},"page":"e0351846","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src\/FAK\/TRIB3 axis"],"prefix":"10.1371","volume":"21","author":[{"given":"Ming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8452-5026","authenticated-orcid":true,"given":"Zhongkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"3","key":"pone.0351846.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"pone.0351846.ref002","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/s41591-025-03793-6","article-title":"Global lifetime estimates of expected and preventable gastric cancers across 185 countries","volume":"31","author":"JY Park","year":"2025","journal-title":"Nat Med"},{"key":"pone.0351846.ref003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2021.06.002","article-title":"Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients","volume":"517","author":"Y Chen","year":"2021","journal-title":"Cancer Lett"},{"issue":"10","key":"pone.0351846.ref004","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2174\/1566524020666201120113538","article-title":"OSI-027 Alleviates Oxaliplatin Chemoresistance in Gastric Cancer Cells by Suppressing P-gp Induction","volume":"21","author":"E Xu","year":"2021","journal-title":"Curr Mol Med"},{"issue":"2","key":"pone.0351846.ref005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3892\/ijmm.2021.4998","article-title":"Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL\u20116\/JAK\/STAT3\u2011mediated PD\u2011L1 activity","volume":"48","author":"X Feng","year":"2021","journal-title":"Int J Mol Med"},{"issue":"22","key":"pone.0351846.ref006","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"J Liu","year":"2022","journal-title":"FEBS J"},{"issue":"1","key":"pone.0351846.ref007","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/genes14010043","article-title":"Ferroptosis: A Novel Type of Cell Death in Male Reproduction","volume":"14","author":"Y Su","year":"2022","journal-title":"Genes (Basel)"},{"issue":"16","key":"pone.0351846.ref008","article-title":"USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy","volume":"121","author":"H Li","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pone.0351846.ref009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"L Zhao","year":"2022","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"pone.0351846.ref010","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41467-024-46776-w","article-title":"Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer","volume":"15","author":"G Bi","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0351846.ref011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"C Zhang","year":"2022","journal-title":"Mol Cancer"},{"key":"pone.0351846.ref012","first-page":"100974","article-title":"Protein tyrosine phosphatase receptor type E (PTPRE) regulates the activation of wild-type KIT and KIT mutants differently","volume":"26","author":"S Zhang","year":"2021","journal-title":"Biochem Biophys Rep"},{"issue":"2","key":"pone.0351846.ref013","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CAD.0000000000001258","article-title":"Circular RNA circ_0073181 contributes to tumorigenesis by regulating protein tyrosine phosphatase receptor type E via miR-548p in hepatocellular carcinoma","volume":"33","author":"Y Wang","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"6","key":"pone.0351846.ref014","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1568009623666230118111745","article-title":"Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1\/2 Signaling Pathway","volume":"23","author":"C Peng","year":"2023","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"pone.0351846.ref015","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hep.31104","article-title":"PTPR\u03b5 Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-\u03b2 Receptor 1","volume":"72","author":"Z Liao","year":"2020","journal-title":"Hepatology"},{"key":"pone.0351846.ref016","doi-asserted-by":"crossref","first-page":"565266","DOI":"10.3389\/fonc.2020.565266","article-title":"miR-631 inhibits intrahepatic metastasis of hepatocellular carcinoma by targeting PTPRE","volume":"10","author":"B Chen","year":"2020","journal-title":"Front Oncol"},{"issue":"8","key":"pone.0351846.ref017","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.3390\/ijms25084572","article-title":"Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma","volume":"25","author":"L Mohren","year":"2024","journal-title":"Int J Mol Sci"},{"key":"pone.0351846.ref018","doi-asserted-by":"crossref","first-page":"116366","DOI":"10.1016\/j.biopha.2024.116366","article-title":"Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma","volume":"173","author":"R Dong","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"pone.0351846.ref019","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1074\/jbc.M111.293928","article-title":"Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1\/2 and AKT protein pathways is required for survival of human breast cancer cells","volume":"287","author":"CE Nunes-Xavier","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0351846.ref020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12032-013-0517-8","article-title":"Deregulation of protein phosphatase expression in acute myeloid leukemia","volume":"30","author":"NN Kabir","year":"2013","journal-title":"Med Oncol"},{"issue":"10","key":"pone.0351846.ref021","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.21873\/anticanres.14580","article-title":"Expression Analysis of Tyrosine Phosphatase Genes at Different Stages of Renal Cell Carcinoma","volume":"40","author":"I Laczmanska","year":"2020","journal-title":"Anticancer Res"},{"issue":"3","key":"pone.0351846.ref022","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/1568009622666220211122745","article-title":"Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy","volume":"22","author":"D Maru","year":"2022","journal-title":"Curr Cancer Drug Targets"},{"issue":"14","key":"pone.0351846.ref023","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer","volume":"18","author":"L Shen","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"4","key":"pone.0351846.ref024","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/cbdd.14281","article-title":"Sulfasalazine inhibits esophageal cancer cell proliferation by mediating ferroptosis","volume":"102","author":"L-B Yin","year":"2023","journal-title":"Chem Biol Drug Des"},{"key":"pone.0351846.ref025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbrc.2021.11.029","article-title":"Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5\/GPX4 axis","volume":"585","author":"H Li","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0351846.ref026","doi-asserted-by":"crossref","first-page":"112052","DOI":"10.1016\/j.intimp.2024.112052","article-title":"NOX4 regulates gastric cancer cell invasion and proliferation by increasing ferroptosis sensitivity through regulating ROS","volume":"132","author":"L Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"pone.0351846.ref027","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3892\/or.2024.8753","article-title":"Ursolic acid inhibits the proliferation of triple\u2011negative breast cancer stem\u2011like cells through NRF2\u2011mediated ferroptosis","volume":"52","author":"X Yang","year":"2024","journal-title":"Oncol Rep"},{"key":"pone.0351846.ref028","doi-asserted-by":"crossref","first-page":"176007","DOI":"10.1016\/j.ejphar.2023.176007","article-title":"Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer","volume":"957","author":"Y Yu","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"24","key":"pone.0351846.ref029","article-title":"ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts","volume":"10","author":"F Jiang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"pone.0351846.ref030","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.redox.2023.102952","article-title":"RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer","volume":"68","author":"Z Xu","year":"2023","journal-title":"Redox Biol"},{"issue":"1","key":"pone.0351846.ref031","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","article-title":"Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer","volume":"9","author":"L Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pone.0351846.ref032","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","article-title":"Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2\/Keap1\/xCT signaling","volume":"26","author":"D Fu","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"pone.0351846.ref033","doi-asserted-by":"crossref","first-page":"114986","DOI":"10.1016\/j.biopha.2023.114986","article-title":"Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis","volume":"164","author":"J Yuan","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"pone.0351846.ref034","doi-asserted-by":"crossref","first-page":"109581","DOI":"10.1016\/j.intimp.2022.109581","article-title":"The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer","volume":"114","author":"A Arif","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"pone.0351846.ref035","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41419-024-07311-3","article-title":"Ovarian cancer-derived TGF-\u03b21 induces cancer-associated adipocytes formation by activating SMAD3\/TRIB3 pathway to establish pre-metastatic niche","volume":"15","author":"T Gao","year":"2024","journal-title":"Cell Death Dis"},{"issue":"3","key":"pone.0351846.ref036","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41419-024-06472-5","article-title":"TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis","volume":"15","author":"L Chen","year":"2024","journal-title":"Cell Death Dis"},{"issue":"1","key":"pone.0351846.ref037","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41420-024-02152-7","article-title":"TRIB3 inhibition by palbociclib sensitizes prostate cancer to ferroptosis via downregulating SOX2\/SLC7A11 expression","volume":"10","author":"Y Zhang","year":"2024","journal-title":"Cell Death Discov"},{"issue":"4","key":"pone.0351846.ref038","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10735-025-10496-2","article-title":"METTL14 induces ferroptosis to inhibit colorectal cancer progression by inhibiting TRIB3 via an m6A-YTHDF2-dependent manner","volume":"56","author":"D Zhang","year":"2025","journal-title":"J Mol Histol"},{"key":"pone.0351846.ref039","doi-asserted-by":"crossref","first-page":"111421","DOI":"10.1016\/j.cellsig.2024.111421","article-title":"TRIB3 knockdown increases the sensitivity of clear cell renal cell carcinoma to sunitinib by inducing ferroptosis","volume":"124","author":"Z Chen","year":"2024","journal-title":"Cell Signal"},{"issue":"52","key":"pone.0351846.ref040","doi-asserted-by":"crossref","first-page":"36048","DOI":"10.1074\/jbc.M114.603548","article-title":"Adaptor protein GRB2 promotes Src tyrosine kinase activation and podosomal organization by protein-tyrosine phosphatase \u03f5 in osteoclasts","volume":"289","author":"E Levy-Apter","year":"2014","journal-title":"J Biol Chem"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:25:42Z","timestamp":1781803542000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351846"}},"subtitle":[],"editor":[{"given":"Marwan Salih","family":"Al-Nimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351846","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}